| Literature DB >> 16436737 |
Paul D Stapleton1, Saroj Shah, Yukihiko Hara, Peter W Taylor.
Abstract
(-)-Epicatechin gallate (ECg) and (-)-epigallocatechin gallate (EGCg) reduce oxacillin resistance in mecA-containing strains of Staphylococcus aureus. Their binding to staphylococcal cells is enhanced by the nongalloyl analogues (-)-epicatechin (EC) and (-)-epigallocatechin (EGC). EC and EGC significantly increased the capacity of ECg and EGCg to reduce levels of staphylococcal oxacillin resistance.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16436737 PMCID: PMC1366925 DOI: 10.1128/AAC.50.2.752-755.2006
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191